CNC (Centene) Interest Expense : $-694 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Centene Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Centene's interest expense for the three months ended in Mar. 2025 was $ -170 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-694 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Centene's Operating Income for the three months ended in Mar. 2025 was $ 1,534 Mil. Centene's Interest Expense for the three months ended in Mar. 2025 was $ -170 Mil. Centene's Interest Coverage for the quarter that ended in Mar. 2025 was 9.02. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centene Interest Expense Historical Data

The historical data trend for Centene's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Interest Expense Chart

Centene Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-728.00

-665.00

-725.00

-702.00

Centene Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-178.00	-176.00	-176.00	-172.00	-170.00

Centene Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-694 Mil.

Centene (NYSE:CNC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centene's Interest Expense for the three months ended in Mar. 2025 was $-170 Mil. Its Operating Income for the three months ended in Mar. 2025 was $1,534 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was $18,308 Mil.

Centene's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	1534	/	-170
	=	9.02

The higher the ratio, the stronger the company's financial strength is.

Centene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Interest Expense

Comparable Companies

HUM MOH OSCR ALHC PGNY CLOV NEUE PFHO ELV CVS UNH CI SZSE:000503 BSP:ODPV3 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 MIL:HI ROCO:6665

Traded in Other Exchanges

CNC:Mexico 1CNC:Italy 0HVB:UK QEN:Germany QEN:Germany C1NC34:Brazil

Address

7700 Forsyth Boulevard, St. Louis, MO, USA, 63105

Website

https://www.centene.com

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.

Executives

Christopher J Coughlin	director
Jessica L. Blume	director	P.O. BOX 407, LAKELAND FL 33802
H James Dallas	director	127 PUBLIC SQUARE, CLEVELAND OH 44114
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Andrew Lynn Asher	officer: EVP, CFO	8735 HENDERSON ROAD, TAMPA FL 33634
Sarah London	officer: SVP, Technology & Innovation	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Kenneth J Fasola	officer: EVP, Health Care Enterprises	500 WEST MAIN STREET, LOUISVILLE KY 40202
Lori Jean Robinson	director	5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
James E Murray	officer: EVP, Chief Transform. Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Monte E Ford	director	C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Shannon Bagley	officer: EVP, Chief Admin. Officer	7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt	director	822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Mark J Brooks	officer: SVP, Chief Information Officer	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
David P Thomas	officer: EVP, MARKETS	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105